Literature DB >> 11822362

Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis.

Damian James Hussey, Alexander Dobrovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11822362     DOI： 10.1182/blood.v99.3.1097

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.

Authors:  Takuro Nakamura
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

3.  Inhibition of the nuclear export of p65 and IQCG in leukemogenesis by NUP98-IQCG.

Authors:  Mengmeng Pan; Qiyao Zhang; Ping Liu; Jinyan Huang; Yueying Wang; Saijuan Chen
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

4.  Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.

Authors:  Catherine Matte-Martone; Jinling Liu; Meng Zhou; Maria Chikina; Douglas R Green; John T Harty; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

5.  The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

Authors:  Jesslyn Saw; David J Curtis; Damian J Hussey; Alexander Dobrovic; Peter D Aplan; Christopher I Slape
Journal:  Leuk Res       Date:  2013-09-21       Impact factor: 3.156

Review 6.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

7.  Coiled coil structures and transcription: an analysis of the S. cerevisiae coilome.

Authors:  Kellie E Barbara; Kristine A Willis; Terry M Haley; Stephen J Deminoff; George M Santangelo
Journal:  Mol Genet Genomics       Date:  2007-05-03       Impact factor: 2.980

8.  LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.

Authors:  Tien-sheng Huang; Line M Myklebust; Endre Kjarland; Bjørn Tore Gjertsen; Frederic Pendino; Øystein Bruserud; Stein Ove Døskeland; Johan R Lillehaug
Journal:  Mol Cancer       Date:  2007-04-23       Impact factor: 27.401
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.